Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MMP1 | P03956 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | MMP12 | P39900 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22946291 | 0.85 | TDP1 (0.61) | TDP1KMT2ASLC6A2SLC6A3CYP1A2 | |
| SCHEMBL9938921 | 0.82 | CYP1A2 (0.72) | KMT2ACYP1A2ALDH1A1MAPTLMNA | |
| SCHEMBL21588491 | 0.81 | ALDH1A1 (0.56) | TDP1KMT2ASLC6A2SLC6A3CYP1A2 | |
| SCHEMBL17485944 | 0.81 | CYP1A2 (0.56) | TDP1KMT2ASLC6A2SLC6A3CYP1A2 | |
| Dipicolinic Acid SCHEMBL5611142 | 0.80 | TDP1 (0.57) | TDP1KMT2ASLC6A2SLC6A3CYP1A2 | |
| SCHEMBL1244820 | 0.80 | TDP1 (0.57) | TDP1KMT2ASLC6A2SLC6A3CYP1A2 | |
| SCHEMBL29030257 | 0.79 | TDP1 (0.55) | TDP1KMT2ASLC6A2SLC6A3CYP1A2 | |
| SCHEMBL20083642 | 0.79 | TDP1 (0.54) | TDP1KMT2ASLC6A2SLC6A3CYP1A2 | |
| SCHEMBL24218219 | 0.79 | POLB (0.57) | TDP1KMT2ASLC6A2SLC6A3ALDH1A1 | |
| SCHEMBL23182815 | 0.79 | ALDH1A1 (0.45) | TDP1KMT2ASLC6A2SLC6A3CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190076436-A1 | MACROCYCLIC COMPOUNDS AS ROS1 KINASE INHIBITORS | ARRAY BIOPHARMA INC. | 2019-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190076436-A1 | MACROCYCLIC COMPOUNDS AS ROS1 KINASE INHIBITORS | ROS1, MAP3K1, MAP3K19 | TDP1 2165/4885KMT2A 547/4885SLC6A2 4862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.